InMode Ltd.
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.- Similar Companies
- Business
- InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Company News
InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program
InMode to Present at Upcoming Investor Conferences and Events
InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges
InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade)
InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade)
Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City
InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript
InMode (INMD) Lags Q1 Earnings Estimates
InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease
Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline
InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock?
InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
InMode to Present at the 24th Annual Needham Virtual Healthcare Conference
Is InMode (INMD) Stock Undervalued Right Now?
InMode Responds to Doma Perpetual's Letters
InMode to Present at Upcoming Investor Conferences
InMode: Plastic Surgery Boom, Cash Flow, And Cheap
InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript